• Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals americanpharmaceuticacreview
    September 30, 2017
    Valeant Pharmaceuticals has completed the sale of the iNova Pharmaceuticals business to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group for $930 million in cash.
PharmaSources Customer Service